1. Home
  2. PYXS vs CODA Comparison

PYXS vs CODA Comparison

Compare PYXS & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYXS
  • CODA
  • Stock Information
  • Founded
  • PYXS 2018
  • CODA 1994
  • Country
  • PYXS United States
  • CODA United States
  • Employees
  • PYXS N/A
  • CODA N/A
  • Industry
  • PYXS Biotechnology: Pharmaceutical Preparations
  • CODA Industrial Machinery/Components
  • Sector
  • PYXS Health Care
  • CODA Industrials
  • Exchange
  • PYXS Nasdaq
  • CODA Nasdaq
  • Market Cap
  • PYXS 101.1M
  • CODA 92.5M
  • IPO Year
  • PYXS 2021
  • CODA N/A
  • Fundamental
  • Price
  • PYXS $1.54
  • CODA $7.92
  • Analyst Decision
  • PYXS Strong Buy
  • CODA Strong Buy
  • Analyst Count
  • PYXS 7
  • CODA 1
  • Target Price
  • PYXS $9.00
  • CODA $11.00
  • AVG Volume (30 Days)
  • PYXS 543.0K
  • CODA 37.5K
  • Earning Date
  • PYXS 03-20-2025
  • CODA 01-29-2025
  • Dividend Yield
  • PYXS N/A
  • CODA N/A
  • EPS Growth
  • PYXS N/A
  • CODA 14.29
  • EPS
  • PYXS N/A
  • CODA 0.32
  • Revenue
  • PYXS $16,146,000.00
  • CODA $20,316,161.00
  • Revenue This Year
  • PYXS N/A
  • CODA $22.31
  • Revenue Next Year
  • PYXS N/A
  • CODA $12.02
  • P/E Ratio
  • PYXS N/A
  • CODA $24.69
  • Revenue Growth
  • PYXS N/A
  • CODA 4.98
  • 52 Week Low
  • PYXS $1.39
  • CODA $5.37
  • 52 Week High
  • PYXS $6.85
  • CODA $9.89
  • Technical
  • Relative Strength Index (RSI)
  • PYXS 43.02
  • CODA 41.34
  • Support Level
  • PYXS $1.50
  • CODA $7.75
  • Resistance Level
  • PYXS $1.67
  • CODA $8.13
  • Average True Range (ATR)
  • PYXS 0.09
  • CODA 0.34
  • MACD
  • PYXS 0.02
  • CODA -0.05
  • Stochastic Oscillator
  • PYXS 53.57
  • CODA 7.22

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.

Share on Social Networks: